EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation

Zhuo Chen iD, Lin Shi iD, Junjie Lu iD, Jing Su iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/2700500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 19.06.2026. Verfasst von Zhuo Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn. Hauptthemen laut MEDLINE: Liver Cirrhosis, Inflammation, Fatty Liver. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development Fund of the Affiliated Hospital of Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasingly prevalent. Life’s Crucial 9 (LC9) combines cardiometabolic and mental health metrics linked to MASLD pathogenesis, but its association with liver fibrosis and prognosis in MASLD remains unknown.

Methods

Using National Health and Nutrition Examination Survey (NHANES) data, we performed a prospective cohort analysis for mortality (2005–2016, n = 2524) and a cross‐sectional analysis for liver fibrosis (2017–2018, n = 1277). Significant fibrosis was defined as liver stiffness measurement (LSM) ≥8.0 kPa by vibration‐controlled transient elastography. Systemic inflammation was assessed using the systemic immune‐inflammation index (SII) and pan‐immune‐inflammation value (PIV). Multivariable regression and mediation analyses were conducted.

Results

Higher LC9 scores were associated with lower liver stiffness ( β = −0.07, 95% CI: −0.12 to −0.01). Each 1‐point increase in LC9 reduced fibrosis risk by 5% (OR = 0.95), with the highest quartile showing the lowest risk (OR = 0.21). Over a median follow‐up of 98 months, each 1‐point LC9 increase was associated with a 3% reduction in all‐cause mortality (HR = 0.97). Lower systemic inflammation partially mediated the LC9‐mortality relationship (SII: 5%, PIV: 6.3%).

Conclusion

Higher LC9 scores are associated with reduced liver fibrosis and improved survival in MASLD, with systemic inflammation partially mediating the mortality association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisInflammationFatty LiverHumansMaleNutrition SurveysFemaleCross-Sectional StudiesMiddle AgedAdultUnited StatesProspective Studies

Stichwörter der Autor:innen

Life Crucial 9all-cause mortalityliver fibrosismediation analysismetabolic dysfunction-associated steatotic liver disease

Autor:innen und Institutionen

  • Department of Gastroenterology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn.
  • Department of Neurology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn.

ORCID-Profile: Zhuo Chen, Lin Shi, Junjie Lu, Jing Su

Förderung

  • Development Fund of the Affiliated Hospital of Xuzhou Medical University

Zitieren

APA

Chen, Z., Shi, L., Lu, J., & Su, J. (2026). Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/2700500

Vancouver

Chen Z, Shi L, Lu J, Su J. Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/2700500

BibTeX
@article{Chen2026,
  author = {Chen, Zhuo and Shi, Lin and Lu, Junjie and Su, Jing},
  title = {Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/2700500}
}
Kostenlos starten →